Pharmacoeconomic evaluation of testing for angiotensinconverting enzyme genotype before starting ß-hydrocy-ß-methylglutaryl coenzyme A reductase inhibitor therapy in men

A.H. Maitland-van der Zee; O.H. Klungel; B.H.Ch. Stricker; D.L. Veenstra; J.J.P. Kastelein; A. Hofman; J.C.M. Witteman; H.G.M. Leufkens; C.M. van Duijn; A. de Boer

Pharmacoeconomic evaluation of testing for angiotensinconverting enzyme genotype before starting ß-hydrocy-ß-methylglutaryl coenzyme A reductase inhibitor therapy in men

A.H. Maitland-van der Zee, O.H. Klungel, B.H.Ch. Stricker, D.L. Veenstra, J.J.P. Kastelein, A. Hofman, J.C.M. Witteman, H.G.M. Leufkens, C.M. van Duijn, A. de Boer

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	53-60
Number of pages	8
Journal	Pharmacogenetics
Volume	14
Publication status	Published - 2004

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

Access to Document

Boer 04 MaitlandPharmacoeconomicEvaluation
Open Access (free)

Cite this

Maitland-van der Zee, A. H., Klungel, O. H., Stricker, B. H. C., Veenstra, D. L., Kastelein, J. J. P., Hofman, A., Witteman, J. C. M., Leufkens, H. G. M., van Duijn, C. M., & de Boer, A. (2004). Pharmacoeconomic evaluation of testing for angiotensinconverting enzyme genotype before starting ß-hydrocy-ß-methylglutaryl coenzyme A reductase inhibitor therapy in men. Pharmacogenetics, 14, 53-60.

@article{b521c97ba33b4e1bb4a94b59fe2bc17f,

title = "Pharmacoeconomic evaluation of testing for angiotensinconverting enzyme genotype before starting {\ss}-hydrocy-{\ss}-methylglutaryl coenzyme A reductase inhibitor therapy in men",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "{Maitland-van der Zee}, A.H. and O.H. Klungel and B.H.Ch. Stricker and D.L. Veenstra and J.J.P. Kastelein and A. Hofman and J.C.M. Witteman and H.G.M. Leufkens and {van Duijn}, C.M. and {de Boer}, A.",

year = "2004",

language = "Undefined/Unknown",

volume = "14",

pages = "53--60",

journal = "Pharmacogenetics",

issn = "0960-314X",

publisher = "Lippincott Williams and Wilkins",

}

Maitland-van der Zee, AH, Klungel, OH, Stricker, BHC, Veenstra, DL, Kastelein, JJP, Hofman, A, Witteman, JCM, Leufkens, HGM, van Duijn, CM & de Boer, A 2004, 'Pharmacoeconomic evaluation of testing for angiotensinconverting enzyme genotype before starting ß-hydrocy-ß-methylglutaryl coenzyme A reductase inhibitor therapy in men', Pharmacogenetics, vol. 14, pp. 53-60.

Pharmacoeconomic evaluation of testing for angiotensinconverting enzyme genotype before starting ß-hydrocy-ß-methylglutaryl coenzyme A reductase inhibitor therapy in men. / Maitland-van der Zee, A.H.; Klungel, O.H.; Stricker, B.H.Ch. et al.
In: Pharmacogenetics, Vol. 14, 2004, p. 53-60.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pharmacoeconomic evaluation of testing for angiotensinconverting enzyme genotype before starting ß-hydrocy-ß-methylglutaryl coenzyme A reductase inhibitor therapy in men

AU - Maitland-van der Zee, A.H.

AU - Klungel, O.H.

AU - Stricker, B.H.Ch.

AU - Veenstra, D.L.

AU - Kastelein, J.J.P.

AU - Hofman, A.

AU - Witteman, J.C.M.

AU - Leufkens, H.G.M.

AU - van Duijn, C.M.

AU - de Boer, A.

PY - 2004

Y1 - 2004

KW - Farmacie/Biofarmaceutische wetenschappen (FARM)

KW - Epidemiology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Ziekenhuisstructuur en organisatie van de gezondheidszorg

KW - Public Health

M3 - Article

SN - 0960-314X

VL - 14

SP - 53

EP - 60

JO - Pharmacogenetics

JF - Pharmacogenetics

ER -